Unique ID issued by UMIN | UMIN000042928 |
---|---|
Receipt number | R000049001 |
Scientific Title | Trial for reduction of anxiety and fatigue -open study- |
Date of disclosure of the study information | 2022/01/13 |
Last modified on | 2024/05/17 12:44:36 |
Trial for reduction of anxiety and fatigue -open study-
Trial for reduction of anxiety and fatigue
Trial for reduction of anxiety and fatigue -open study-
Trial for reduction of anxiety and fatigue
Japan |
Healthy adults
Adult |
Others
NO
To examine the effects of ingesting the test food for 4 weeks on anxiety and fatigue in women aged between 50 and 65 years.
Safety
fatigue
VAS score(anxiety fatigue)
QOL questionnaire (behavior changes)
Sleep questionnaire (SMH)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Food |
Take 2 tablets of test food with water twice a day
50 | years-old | <= |
65 | years-old | > |
Female
1. Aged 20 to under 65 at the time of informed consent.
2. Japanese females.
3. Those who are menopausal.
4. Those who do not need treatment but have anxiety of fatigue.
5. Those who feel more anxious than last year.
6. Those who can input electronic diary with smartphone / PC.
7. Those who understand the contents of the study and obtain written consent before the test based on the person's free will.
Subjects who
1. are currently receiving any types of medicines and/or Chinese medical treatment (except for the drugs taken as needed).
2. plan to change their lifestyle during the test.
3. have a serious illness such as liver, kidney, heart, respiratory tract, endocrine, metabolic disease, etc..
4. are receiving treatment for mental illness such as depression or anxiety disorder, or have a history of it.
5. May take sleeping pills/ sleep-inducing drugs during the test period, continuously or when they need.
6. Have been diagnosed with chronic fatigue syndrome.
7. Have had life events that affect their mind and body such as loss of important things within one month (death of relatives, loss of employment, divorce, pet death).
8. Take healthy foods or supplements daily. (acceptable if they can stop taking after obtaining consent.)
9. have a past and current medical history of drug or food allergy.
10. have participated in other clinical trials within one month before obtaining consent, or those who plan to participate during the trial period.
11. consume alcohol excessively (alcohol equivalent 60g or more / day).
12. have smoking habit.
13. have an irregular diet, or irregular life rhythms (work in shifts, work late at night etc.).
14. are judged by the investigator to be unsuitable for participating in this study.
20
1st name | Kiyoshi |
Middle name | |
Last name | Nakamura |
Kunitachi Sakura Hospital
Chairman
186-0002
1-19-10 Higashi, Kunitachi-shi, Tokyo
042-577-1011
clinical-trial@imeqrd.co.jp
1st name | Yoshitada |
Middle name | |
Last name | Hira |
IMEQRD Co., Ltd.
Planning and Sales Department
104-0061
6-2-1 Ginza Chuo-ku Tokyo
03-6704-5968
clinical-trial@imeqrd.co.jp
IMEQRD inc.
Integrate co., ltd.
Profit organization
Suda Clinic institutional review board
2-8-14,Takadanobaba,Shinjyuku,Tokyo
03-3207-8161
jimukyoku@imeqrd.co.jp
NO
2022 | Year | 01 | Month | 13 | Day |
Unpublished
Completed
2020 | Year | 12 | Month | 11 | Day |
2020 | Year | 12 | Month | 17 | Day |
2021 | Year | 01 | Month | 14 | Day |
2021 | Year | 03 | Month | 02 | Day |
2021 | Year | 01 | Month | 06 | Day |
2024 | Year | 05 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049001